Stay updated on Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial
Sign up to get notified when there's something new on the Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial page.

Latest updates to the Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial page
- Check2 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA comprehensive Locations section has been added, listing trial sites by country and city (e.g., Anhui, Beijing, Chongqing, etc.), and the previous location listings have been removed in Revision: v3.3.3.SummaryDifference2%

- Check54 days agoChange DetectedMinor wording adjustments in the Publications section: the relation to results is slightly reworded and the revision labels updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the banner about government funding delays and operating status; the notice that information may not be up to date is no longer shown.SummaryDifference0.3%

- Check83 days agoChange DetectedNo significant additions or deletions were detected on the Study Details page; core information such as study design, eligibility, endpoints, and locations appears unchanged.SummaryDifference0.3%

- Check104 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference3%

Stay in the know with updates to Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial page.